Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
Treatment with interferon beta-1a plus the antiviral remdesivir was not superior to remdesivir alone.
Molnupiravir reduces severe illness and death, but it must be started within days after developing symptoms.
Collins has led the NIH under three presidents over more than 12 years.
A steady stream of spurious claims about COVID-19 vaccines and treatments swirl around the public consciousness.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
The government-wide effort aims to develop the next generation of COVID-19 treatments to prepare the U.S. to respond to future virus threats
Researchers used an airway-on-a-chip that mimics living lung tissue to screen approved drugs for use against SARS-CoV-2.
Molnupiravir, previously studied for hepatitis C, might be able to prevent or treat COVID-19 outside of a clinical setting.
We owe these early fighters a debt of gratitude for transforming our response to public health crises.
Experts provide recommendations for both treatment and prevention of COVID-19 for people with cancer.
At the current pace, only about 20% of the world’s population will be vaccinated by the end of 2021.
Bamlanivimab and etesevimab may be given to people with mild to moderate COVID-19 who are at high risk for progression to severe disease.
Even as drugmakers ramp up supplies, only a trickle of the product has found its way into regular people.
Plitidepsin, derived from a sea squirt, may be far more potent than remdesivir against the coronavirus.
Full-dose anticoagulation treatment for moderately ill COVID-19 patients reduced the need for ventilators.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.